Firm Analyst
H.C. Wainwright & Co. Edward Arce
Maxim Group Jason McCarthy, Ph.D.
ROTH Capital Partners Elemer Piros, Ph.D.
The Benchmark Company, LLC Bruce Jackson

Unicycive Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Unicycive Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Unicycive Therapeutics, Inc. or its management. Unicycive Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.